NCT05157945View on ClinicalTrials.gov

ALTO-300 in Depression (ALTO-300-004)

PHASE2CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

April 26, 2023

Study Completion Date

May 5, 2023

Conditions
Major Depressive Disorder
Interventions
DRUG

ALTO-300 PO Tablet

One tablet daily

Trial Locations (4)

10013

Cerebral - New York City, New York

30324

Cerebral - Atlanta, Atlanta

39216

Site 171, Jackson

75212

Cerebral - Dallas, Dallas

Sponsors

Lead Sponsor

Alto Neuroscience
All Listed Sponsors
lead

Alto Neuroscience

INDUSTRY